This week’s Medicare updates include a final rule on Medicare Advantage drug pricing, the quarterly update for HCPCS drug/biological codes, an update to claim status and claim status category codes, and more!
CMS modified its proposal to expand prior authorization and step therapy to protected classes of drugs for Part D and Medicare Advantage beneficiaries, according to a final rule released May 16.
Researchers at the Regenstrief Institute and Indiana University have developed a new tool for providers to track and potentially identify the early onset of serious underlying issues relevant for multiple chronic conditions that may otherwise go undetected.
Not all governance, risk management, and compliance (GRC) solutions are built the same. If you’re in the market for one and are working in the healthcare industry, check out ComplyAssistant.
